Imunon, Inc. (Nasdaq:IMNN)

Health Care/Life Sciences • Biotechnology

CIK 749647

Company

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Address
997 Lenox Drive
Suite 100
Lawrenceville, New Jersey 08648

Employees
33

Stock Info

Close
$0.8800

Day Range
0.8695 - 0.9000

52 Week Range
0.6400 - 3.6500

Average volume
237.9K

Short Interest
986.15K (02/14/25)

% of Float Shorted
7.09%

Market Cap
$12.87M

Revenue
N/A

Net Income
-$19.51M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$1.6490

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Executive Chairman
Michael H. Tardugno

Independent Director
Christine A. Pellizzari

Independent Director
James E. Dentzer

Independent Director
Frederick J. Fritz

Independent Director
Donald P. Braun

SEC filings

Date	Form	Event
19 Dec, 2024	4
27 Nov, 2024	8-K
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G
7 Nov, 2024	10-Q
7 Nov, 2024	8-K
31 Oct, 2024	4/A
8 Oct, 2024	4
7 Oct, 2024	8-K
7 Oct, 2024	3
27 Sep, 2024	424B3
26 Sep, 2024	EFFECT
24 Sep, 2024	CORRESP
20 Sep, 2024	S-1/A
10 Sep, 2024	4
10 Sep, 2024	4
10 Sep, 2024	4
10 Sep, 2024	4
10 Sep, 2024	4
10 Sep, 2024	4
10 Sep, 2024	4
5 Sep, 2024	UPLOAD
3 Sep, 2024	8-K
3 Sep, 2024	424B5
29 Aug, 2024	S-8
29 Aug, 2024	S-1
16 Aug, 2024	4
16 Aug, 2024	D
16 Aug, 2024	4
14 Aug, 2024	10-Q
14 Aug, 2024	8-K
5 Aug, 2024	SC 13G
1 Aug, 2024	8-K
1 Aug, 2024	424B5
31 Jul, 2024	8-K
30 Jul, 2024	8-K
14 Jun, 2024	4
14 Jun, 2024	4
14 Jun, 2024	4
14 Jun, 2024	4
14 Jun, 2024	4
14 Jun, 2024	4
14 Jun, 2024	4
13 Jun, 2024	8-K
10 Jun, 2024	3
22 May, 2024	EFFECT
20 May, 2024	8-K
20 May, 2024	UPLOAD
20 May, 2024	CORRESP
15 May, 2024	S-3
14 May, 2024	4
13 May, 2024	8-K
13 May, 2024	10-Q
8 May, 2024	8-K
29 Apr, 2024	ARS
26 Apr, 2024	DEF 14A
11 Apr, 2024	8-K
10 Apr, 2024	RW
28 Mar, 2024	8-K
28 Mar, 2024	10-K
18 Mar, 2024	4
18 Mar, 2024	8-K
18 Mar, 2024	4
18 Mar, 2024	4
18 Mar, 2024	4
18 Mar, 2024	4
18 Mar, 2024	4
18 Mar, 2024	4
18 Mar, 2024	4
12 Mar, 2024	8-K	CEO Change
9 Feb, 2024	S-1/A
18 Jan, 2024	S-1/A
29 Dec, 2023	8-K
20 Dec, 2023	S-1
11 Dec, 2023	3
11 Dec, 2023	8-K
11 Dec, 2023	4
14 Nov, 2023	10-Q
14 Nov, 2023	8-K
11 Aug, 2023	S-8
10 Aug, 2023	8-K
10 Aug, 2023	10-Q
15 Jun, 2023	8-K
14 Jun, 2023	8-K
26 May, 2023	UPLOAD
11 May, 2023	8-K
11 May, 2023	10-Q
5 May, 2023	CORRESP
3 May, 2023	UPLOAD
28 Apr, 2023	DEF 14A
28 Apr, 2023	DEFA14A
30 Mar, 2023	10-K
30 Mar, 2023	8-K
24 Mar, 2023	8-K
21 Mar, 2023	4
21 Mar, 2023	4
21 Mar, 2023	4
21 Mar, 2023	4
21 Mar, 2023	4
21 Mar, 2023	4
21 Mar, 2023	4
21 Mar, 2023	4
21 Mar, 2023	4
21 Mar, 2023	4
10 Feb, 2023	8-K
3 Jan, 2023	8-K
15 Nov, 2022	8-K
14 Nov, 2022	10-Q
14 Nov, 2022	8-K
3 Oct, 2022	8-K	CEO Change
3 Oct, 2022	3
3 Oct, 2022	4
19 Sep, 2022	8-K
15 Aug, 2022	S-8
15 Aug, 2022	8-K
15 Aug, 2022	10-Q
20 Jul, 2022	4
20 Jul, 2022	3
19 Jul, 2022	8-K	CEO Change
15 Jun, 2022	4
15 Jun, 2022	4
15 Jun, 2022	4
15 Jun, 2022	4
15 Jun, 2022	4
15 Jun, 2022	4
15 Jun, 2022	4
15 Jun, 2022	4
15 Jun, 2022	4
15 Jun, 2022	4
14 Jun, 2022	8-K
25 May, 2022	8-K
25 May, 2022	424B5
16 May, 2022	10-Q
16 May, 2022	8-K
29 Apr, 2022	DEF 14A
12 Apr, 2022	4
11 Apr, 2022	4
8 Apr, 2022	424B5
7 Apr, 2022	8-K
31 Mar, 2022	10-K
31 Mar, 2022	8-K
16 Mar, 2022	8-K
7 Mar, 2022	4
7 Mar, 2022	4
7 Mar, 2022	4
7 Mar, 2022	4
7 Mar, 2022	4
7 Mar, 2022	4
7 Mar, 2022	4
7 Mar, 2022	4
7 Mar, 2022	4
4 Mar, 2022	8-K
3 Mar, 2022	4
28 Feb, 2022	8-K
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G/A
26 Jan, 2022	DEFA14A
25 Jan, 2022	DEF 14A
14 Jan, 2022	PRE 14A
14 Jan, 2022	8-K
12 Jan, 2022	424B5
12 Jan, 2022	424B5
11 Jan, 2022	8-K
30 Dec, 2021	8-K
16 Dec, 2021	3
16 Dec, 2021	4
10 Dec, 2021	8-K
3 Dec, 2021	8-K
15 Nov, 2021	8-K
15 Nov, 2021	10-Q
8 Oct, 2021	4
12 Aug, 2021	8-K
12 Aug, 2021	10-Q
21 Jun, 2021	8-K
10 Jun, 2021	8-K
9 Jun, 2021	4
9 Jun, 2021	3
8 Jun, 2021	4
8 Jun, 2021	3
7 Jun, 2021	DEFA14A
7 Jun, 2021	8-K
4 Jun, 2021	8-K
4 Jun, 2021	DEFA14A
27 May, 2021	DEFA14A
20 May, 2021	4
14 May, 2021	10-Q
14 May, 2021	8-K
20 Apr, 2021	DEF 14A
12 Apr, 2021	PRER14A
8 Apr, 2021	PRE 14A
2 Apr, 2021	424B5
2 Apr, 2021	8-K
30 Mar, 2021	EFFECT
26 Mar, 2021	CORRESP
24 Mar, 2021	UPLOAD
22 Mar, 2021	4
22 Mar, 2021	4
22 Mar, 2021	4
22 Mar, 2021	4
22 Mar, 2021	4
22 Mar, 2021	4
22 Mar, 2021	4
22 Mar, 2021	4
19 Mar, 2021	S-3
19 Mar, 2021	10-K
19 Mar, 2021	8-K
11 Feb, 2021	8-K
3 Feb, 2021	8-K
1 Feb, 2021	SC 13G
29 Jan, 2021	SC 13G
29 Jan, 2021	8-K
29 Jan, 2021	SC 13G
29 Jan, 2021	SC 13G/A
25 Jan, 2021	SC 13D
25 Jan, 2021	424B5
25 Jan, 2021	424B5
25 Jan, 2021	8-K
22 Jan, 2021	S-3MEF
21 Jan, 2021	8-K

Last update:2025-03-06 12:48:20.385464

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.